Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition

Onconetix, Inc. (NASDAQ: ONCO) announced an additional advance of $500,000 to Realbotix LLC, the target of its pending acquisition, under a strategic bridge financing facility. This brings the total principal outstanding to $3,000,000 and was disclosed in a press release and 8-K filing.